Can a large hepatoma cause Budd‑Chiari syndrome?

Can a Large Hepatoma Cause Budd-Chiari Syndrome?

Yes, a large hepatoma (hepatocellular carcinoma) can absolutely cause Budd-Chiari syndrome through secondary obstruction of hepatic venous outflow, though this represents "secondary" BCS rather than the more common "primary" form.

Understanding the Mechanism

Budd-Chiari syndrome (BCS) is classified into two distinct categories 1:

• Primary BCS: Caused by thrombosis without compression or invasion by malignancy
• Secondary BCS: Caused by compression, invasion by malignancy, or parasites

Hepatocellular carcinoma causes secondary BCS through direct invasion or compression of the hepatic veins and/or inferior vena cava 1. This is a well-recognized mechanism, though the guidelines focus primarily on primary BCS due to different therapeutic and prognostic implications.

Clinical Evidence

Multiple case reports document this phenomenon:

• A 68-year-old patient with hepatocellular carcinoma developed BCS through direct invasion of the right hepatic vein extending to the inferior vena cava 2
• The invasive complications involving hepatic and caval veins define the syndrome, creating posthepatic portal hypertension that adds to pre-existing intrahepatic and prehepatic hypertension 2
• Additional cases confirm ultrasonic detection of BCS secondary to hepatoma 3

Critical Distinction for Management

This distinction between primary and secondary BCS is crucial because treatment approaches differ fundamentally:

For Primary BCS (thrombotic):

• Immediate indefinite anticoagulation with LMWH followed by vitamin K antagonists (INR 2-3) 1
• Stepwise algorithm: anticoagulation → angioplasty/stenting → TIPS → liver transplantation 1

For Secondary BCS from Hepatoma:

• Anticoagulation is not the primary treatment
• Focus shifts to treating the underlying malignancy
• Prognosis is determined by the cancer stage and resectability
• The hepatic venous obstruction is a complication of the tumor burden

Diagnostic Approach

When you suspect BCS in a patient with known or suspected hepatoma:

1. First-line imaging: Doppler ultrasound (>75% sensitivity) 1
2. Confirmatory imaging: MRI or CT to characterize the mass and venous involvement 1
3. Venography: If diagnosis uncertain or to map anatomy before intervention 1
4. Liver biopsy: Only if imaging fails to demonstrate large vein obstruction and small vessel thrombosis is suspected 1

Common Pitfall to Avoid

Do not automatically start anticoagulation when you see BCS on imaging without first determining whether it's primary or secondary. If a large hepatoma is causing venous obstruction through invasion or compression, anticoagulation will not address the underlying problem and may increase bleeding risk, particularly given that these patients often have underlying cirrhosis and portal hypertension 1.

Clinical Presentation Overlap

Both primary and secondary BCS present similarly:

• Ascites (83% of cases)
• Hepatomegaly (67% of cases)
• Abdominal pain
• Signs of portal hypertension including variceal bleeding 1, 2

The key is identifying the cause of the obstruction through imaging to guide appropriate therapy.